SCHEMBL1033367

SCHEMBL1033367

CCOC(=O)Oc1sc2nc(-c3ccc(F)cc3)cn2c1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.56
TSHR P16473 3/20 0.56
MAPT P10636 7/20 0.53
HSD17B10 Q99714 3/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
ALDH1A1 P00352 3/20 0.52
NPSR1 Q6W5P4 3/20 0.52
TP53 P04637 4/20 0.50
HPGD P15428 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
KDM4E B2RXH2 2/20 0.50
THRB P10828 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
USP2 O75604 1/20 0.48
CASP1 P29466 1/20 0.48
PPARG P37231 1/20 0.48
NCOA2 Q15596 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031306 0.91 MAPT (0.48) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1036722 0.88 MAPT (0.56) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1034966 0.87 LMNA (0.57) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1034600 0.86 MAPT (0.55) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1035487 0.85 MAPT (0.54) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1036696 0.84 MAPT (0.58) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1034956 0.83 TP53 (0.56) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1031278 0.81 LMNA (0.66) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1032638 0.81 MAPT (0.46) LMNATSHRMAPTHSD17B10NPC1
SCHEMBL1030953 0.80 NPC1 (0.55) LMNATSHRMAPTHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2086537-B1 IMIDAZO[2,1-B]THIAZOLES AND THEIR USE AS PHARMACEUTICALS SANOFI AVENTIS (FR) 2011-01-26 EP claimed